Close
Scott Dziengelski is a Consultant with the FDA & Life Sciences team who focuses on advocacy before Congress and the federal agencies (HHS, CMS and FDA) on legislative and regulatory issues impacting hospitals, drug and device manufacturers, pharmacies, and other healthcare providers. Scott has nearly 20 years of experience in creating, communicating, and implementing aggressive policy agendas, as well as in developing new coalitions and coordinating diverse interests.
Additionally, he is an adjunct fellow at the Manhattan Institute where he examines policies and regulations impacting individuals with serious mental illnesses and substance use disorders with a focus on quality, access, and outcomes. Prior to joining King & Spalding Scott was the Director of Policy, Quality, and Regulation at the National Association of Behavioral Healthcare (NABH). Scott was also a Legislative Director in the House of Representatives and worked for the House Energy and Commerce Committee.
Scott has a bachelor’s degree in public policy from American University and a master’s degree in psychology from Pepperdine University. He has also won multiple awards including a “Medal of Merit” from the United States Capitol Police and the “Friend of Children’s Mental Health Award” from the American Academy of Child & Adolescent Psychiatry.
back
